SpyGlass Pharma, Inc
Fundamentals
Oldest to newest| Line | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating income | none on file | −$27.1M | −$41.4M |
| Net income | none on file | −$29.2M | −$39.9M |
| Operating cash flow | none on file | −$22.0M | −$32.7M |
| Free cash flow | none on file | −$24.0M | −$33.5M |
| Cash | $15.8M | $16.3M | $96.4M |
| Shares outstanding | none on file | 2.2M | 2.2M |